JP2004503546A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503546A5
JP2004503546A5 JP2002510461A JP2002510461A JP2004503546A5 JP 2004503546 A5 JP2004503546 A5 JP 2004503546A5 JP 2002510461 A JP2002510461 A JP 2002510461A JP 2002510461 A JP2002510461 A JP 2002510461A JP 2004503546 A5 JP2004503546 A5 JP 2004503546A5
Authority
JP
Japan
Prior art keywords
group
carbon atoms
independently
configuration
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002510461A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004503546A (ja
JP5054877B2 (ja
Filing date
Publication date
Priority claimed from FR0007507A external-priority patent/FR2810039B1/fr
Application filed filed Critical
Publication of JP2004503546A publication Critical patent/JP2004503546A/ja
Publication of JP2004503546A5 publication Critical patent/JP2004503546A5/ja
Application granted granted Critical
Publication of JP5054877B2 publication Critical patent/JP5054877B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002510461A 2000-06-13 2001-06-13 環式尿素化合物及びその調製方法 Expired - Fee Related JP5054877B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR00/07507 2000-06-13
FR0007507A FR2810039B1 (fr) 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation
PCT/FR2001/001837 WO2001096318A1 (fr) 2000-06-13 2001-06-13 Composes urees cycliques et leur procede de preparation

Publications (3)

Publication Number Publication Date
JP2004503546A JP2004503546A (ja) 2004-02-05
JP2004503546A5 true JP2004503546A5 (enExample) 2008-07-17
JP5054877B2 JP5054877B2 (ja) 2012-10-24

Family

ID=8851208

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002510461A Expired - Fee Related JP5054877B2 (ja) 2000-06-13 2001-06-13 環式尿素化合物及びその調製方法

Country Status (13)

Country Link
US (1) US7186828B2 (enExample)
EP (2) EP1640368A3 (enExample)
JP (1) JP5054877B2 (enExample)
KR (1) KR20030031001A (enExample)
AT (1) ATE386728T1 (enExample)
AU (2) AU6764501A (enExample)
CA (2) CA2412782C (enExample)
DE (1) DE60132891T2 (enExample)
DK (1) DK1289968T3 (enExample)
ES (1) ES2301554T3 (enExample)
FR (1) FR2810039B1 (enExample)
IL (1) IL153408A0 (enExample)
WO (1) WO2001096318A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006016168D1 (de) * 2005-12-29 2010-09-23 Immupharma France Sa 1,3,5-triazepin-dionen zur Behandlung von Malaria
AU2006331355B2 (en) * 2005-12-29 2011-09-29 Immupharma France Sa Compositions and methods for the inhibition of phospholipase A2
US7777030B2 (en) 2005-12-29 2010-08-17 Centre National de la Recherge Scientifique (CNRS) Compositions and methods for the treatment and prevention of disease
AU2006331357B2 (en) * 2005-12-29 2012-05-17 Immupharma France Sa Compositions and methods for synthesizing novel heterocyclic therapeutics
JP2009522236A (ja) * 2005-12-29 2009-06-11 イミュファルマ・フランス・エスアー マラリアまたはエイズの処置のためのアザ複素環化合物
US8563115B2 (en) 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
EP2548869A1 (en) * 2011-07-20 2013-01-23 Cytec Technology Corp. Process for the Synthesis of N-substituted Cyclic Alkylene Ureas
CN102911130B (zh) * 2011-08-03 2015-05-20 北京师范大学 一种一锅法合成脲四元环化合物的方法、合成的脲四元环化合物
EP3640263A1 (en) 2013-08-21 2020-04-22 UREKA Sarl Peptide-oligourea chimeric compounds and methods of their use
WO2016207726A1 (en) 2015-06-22 2016-12-29 Ureka Sarl Bioinspired catalysis using oligourea helical foldamers
WO2017037142A1 (en) 2015-08-31 2017-03-09 Centre National De La Recherche Scientifique (Cnrs) Foldamer helix bundle-based molecular encapsulation
AU2017252015A1 (en) 2016-04-19 2018-11-08 Ureka Sarl Peptide-oligourea foldamer compounds and methods of their use
US12434075B2 (en) * 2021-05-11 2025-10-07 Celestial Oncology Inc. Coupled robotic radiation therapy system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847760A1 (de) * 1978-11-03 1980-05-14 Hoechst Ag Verfahren zur herstellung von 1,3,5-triaza-2,4,6-triketo-cycloheptan- 3,5-di-essigsaeureestern
US4918186A (en) * 1986-05-06 1990-04-17 Mitsui Toatsu Chemicals, Inc. Process for producing cyclic ureas
KR100268694B1 (ko) * 1991-10-11 2000-10-16 미리암 디. 메코너헤이, 블레어큐. 퍼거슨 레트로바이러스 프로테아제 억제제로 유용한 시클릭 우레아 및 유사체
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5637780A (en) 1993-03-30 1997-06-10 The Dupont Merck Pharmaceutical Company Method for preparing alkylating agents and their use for alkylating cyclic ureas
US5508400A (en) * 1994-04-20 1996-04-16 The Du Pont Merck Pharmaceutical Company Preparation of cyclic urea compounds
AU5310096A (en) * 1995-03-17 1996-10-08 Du Pont Merck Pharmaceutical Company, The Cyclic urea hiv protease inhibitors
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
WO1997008150A1 (en) 1995-08-22 1997-03-06 The Du Pont Merck Pharmaceutical Company Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors
NZ335919A (en) 1996-11-08 2000-09-29 Du Pont Pharm Co (4r,5s,6s,7r)-hexahydro-1-[5-(3-aminoinazole)methyl]-3-butyl-5 ,6-dihydroxy-4,7-bis[phaenylmethyl]-2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor

Similar Documents

Publication Publication Date Title
JP2009538336A5 (enExample)
KR101216249B1 (ko) 5-(메틸-1h-이미다졸-1-일)-3-(트리플루오로메틸)-벤젠아민의 합성 방법
JP2002527414A5 (enExample)
JPH1180090A5 (enExample)
EP1106607A3 (en) Uracil compounds and their use
KR910009669A (ko) 치환된 n-(이미다졸릴)알킬 알라닌 유도체
DE50113943D1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
HUP0300856A2 (hu) Eljárás szubsztituált fenil-acetonitrilek elżállítására
DK1246812T3 (da) Fremgangsmåde til fremstilling af citalopram
HU0201083D0 (enExample)
JP2005514332A5 (enExample)
JPH07242627A (ja) ピロールのアルコキシメチル化
EA200200939A1 (ru) Способ получения циталопрама
DK1404642T3 (da) Fremgangsmåde til fremstillimg af 7-amino-syn-3,5-dihydroxyheptansyrederivater, mellemprodukter derfor og fremgangsmåder til deres fremstilling
JP2001518468A5 (enExample)
CN1058965A (zh) 制备新的喹啉衍生物的方法
EP1323718A3 (en) Haptens, immunogens and antibodies to oxycodone and its metabolites
KR840005449A (ko) 벤조티오 피라노 피리디논
CA2297279A1 (fr) Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP7506415B2 (ja) Vanin-1阻害剤
EP1127873A3 (en) Process for preparing substituted Benzoyl Cyanide Amidinohydrazones
JP2001072649A5 (enExample)
EE200300424A (et) Meetod ftalaani valmistamiseks
JP2021095514A5 (enExample)
JP2005506324A5 (enExample)